DAVID P LUCI
CIK 1271123 · President and CEO · last filed 2026-04-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.75M
Companies
5
Total Filings
20
Lifetime Open-Market Net
$175.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACXP | President and CEO | 1,112,541 | $1.57 | $1.75M | $150.0K | 9 | 2026-04-22 |
| Enveric Biosciences, Inc. (AMRHW) Delisted | Director | 2,430 | — | — | $0 | 1 | 2018-08-22 |
| PLx Pharma Inc. (PLXP) Delisted | Director | — | $0.09 | — | $0 | 1 | 2017-04-21 |
| PLx Pharma Inc. (DPRX) Delisted | President, CEO, Secretary | 1,836,909 | — | — | $25.0K | 3 | 2016-01-21 |
| BIOENVISION INC (BIVN) Delisted | EVP & General Counsel | 0 | — | — | $0 | 2 | 2007-07-12 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-21 | PLx Pharma Inc. (PLXP) Delisted | Mixed | — | $0 | EDGAR |
| 2016-01-21 | PLx Pharma Inc. (DPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-29 | PLx Pharma Inc. (DPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-19 | PLx Pharma Inc. (DPRX) Delisted | Mixed | +2,083 | $25.0K | EDGAR |
| 2009-11-02 | — | Mixed | +263,217 | $70.2K | |
| 2008-04-24 | — | Grant (A) | — | $0 | |
| 2008-01-04 | — | Buy (P) | +3,000 | $1.8K | |
| 2007-07-12 | BIOENVISION INC (BIVN) Delisted | U | −310,154 | -$1.74M | EDGAR |
| 2007-01-08 | — | Grant (A) | — | $0 | |
| 2007-01-05 | BIOENVISION INC (BIVN) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.